IR NewsInvestors

Investors
2021 IR News

IR News 2021

Dec 29, 2021

ANNOUNCEMENT

Carna Announces Initiation of MAD study of Phase 1 Clinical Study for AS-0871

Dec 27, 2021

NEWS

Updated the pipeline following the advancement of the program out-licensed to Gilead and our STING antagonist program.

Dec 23, 2021

FINANCIALS

Revision of Results Forecast for the Fiscal Year Ending December 31, 2021

Dec 23, 2021

ANNOUNCEMENT

Carna Receives First Milestone Payment from Gilead

Dec 21, 2021

ANNOUNCEMENT

Carna Announces to Extend the Agreement with Sumitomo Dainippon Pharma on Joint Research, Development, and Commercialization of Kinase Inhibitors

Dec 03, 2021

ANNOUNCEMENT

Carna Announces Initiation of BA part of Phase 1 Clinical Study for AS-1763

Nov 08, 2021

FINANCIALS

FY2021 Q3 Presentation

Nov 08, 2021

FINANCIALS

Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2021

Oct 06, 2021

ANNOUNCEMENT

Publication in Journal of Medicinal Chemistry Describing the Discovery of CDC7 Inhibitor AS-0141

Sep 17, 2021

ANNOUNCEMENT

Publication in Journal of Medicinal Chemistry Describing the Discovery of BTK Inhibitor AS-1763

Aug 10, 2021

FINANCIALS

FY2021 Q2 Presentation

Aug 06, 2021

FINANCIALS

Consolidated Financial Results for the Second Quarter of the Year Ending December 31, 2021

Jul 26, 2021

ANNOUNCEMENT

Carna Announces Completion of Dosing in Phase 1 SAD Study of AS-1763

Jul 14, 2021

ANNOUNCEMENT

Corporate Presentation July 2021

Jul 12, 2021

ANNOUNCEMENT

Carna Announces Positive Results for AS-0871 Phase 1 Single Ascending Dose Clinical Trial

Jun 14, 2021

ANNOUNCEMENT

Carna Announces Dosing of the First Patient in a First-in-Human Phase 1 Study of AS-0141

May 10, 2021

FINANCIALS

Financial Results FY2021Q1

May 10, 2021

FINANCIALS

Consolidated Financial Results for the First Quarter of the Year Ending December 31, 2021

Apr 28, 2021

ANNOUNCEMENT

Carna Announces Dosing of First Subject in Phase 1 Clinical Trial of AS-1763

Mar 01, 2021

ANNOUNCEMENT

Carna announces clearance of CTA to initiate clinical trial of AS-1763

Feb 22, 2021

ANNOUNCEMENT

Carna announces completion of PMDA review for a clinical trial notification to initiate clinical trial of AS-0141

Feb 15, 2021

FINANCIALS

Financial Results FY2020

Feb 12, 2021

FINANCIALS

Consolidated Financial Results for the Year Ended December 31, 2020